Over the past two centuries, vaccines have been critical for the prevention of infectious
diseases and are considered milestones in the medical and public health history. The World …

Respiratory infections are a major public health concern caused by pathogens that colonize
and invade the respiratory mucosal surface. Nasal vaccines have the advantage of …

The nasal mucosa is an important initial site of host defense against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection. However, intramuscularly administered …

Background Breakthrough severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection in coronavirus disease 2019 (COVID-19) vaccinees typically produces milder …

The development of efficient mucosal vaccines is strongly dependent on the use of
appropriate vectors. Various biological systems or synthetic nanoparticles have been …

Global pandemics are most likely initiated via zoonotic transmission to humans in which
respiratory viruses infect airways with relevance to mucosal systems. Out of the known …

Mucosal vaccines have great potential and advantages in preventing infection caused by
multiple pathogens. In developing mucosal vaccines, the biggest challenge comes from …

Despite the fact that pneumonia remains a leading cause of mortality and morbidity in pre-
weaned calves, relatively little is known regarding the effects of the concurrent …

Vaccines are essential tools to prevent infection and control transmission of infectious
diseases that threaten public health. Most infectious agents enter their hosts across mucosal …

Microalgae are promising production platforms for the cost-effective production of
recombinant proteins. We have recently established that the red alga Porphyridium …